Markus Welcker
- Oncology top 1%
- Cancer-related Molecular Pathways 18
- Peptidase Inhibition and Analysis 5
- Cell Biology top 1%
- Microtubule and mitosis dynamics 7
- Molecular Biology top 1%
- Ubiquitin and proteasome pathways 17
- RNA modifications and cancer 4
- Epigenetics and DNA Methylation 4
- Protein Degradation and Inhibitors 4
- Cancer Research top 5%
- Hematology top 5%
-
- Genetics and Neurodevelopmental Disorders 5
Markus Welcker
31 papers receiving 5.0k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Oncology 2.2k
- Cell Biology 1.1k
- Molecular Biology 4.2k
- Cancer Research 626
- Hematology 298
Countries citing papers authored by Markus Welcker
This map shows the geographic impact of Markus Welcker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Welcker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Welcker more than expected).
Fields of papers citing papers by Markus Welcker
This network shows the impact of papers produced by Markus Welcker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Welcker. The network helps show where Markus Welcker may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Markus Welcker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 34 | |
| 2 | 2019 | 26 | |
| 3 | 2014 | 275 | |
| 4 | 2013 | 77 | |
| 5 | 2008 | 77 | |
| 6 | 2008 | 134 | |
| 7 | 2007 | 138 | |
| 8 | 2007 | 104 | |
| 9 | 2007 | 46 | |
| 10 | FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiationbreakdown → | 2007 | 856 |
| 11 | 2005 | 12 | |
| 12 | 2005 | 22 | |
| 13 | 2005 | 9 | |
| 14 | The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradationbreakdown → | 2004 | 756 |
| 15 | 2004 | 62 | |
| 16 | 2004 | 115 | |
| 17 | 2003 | 302 | |
| 18 | 2002 | 98 | |
| 19 | 2001 | 28 | |
| 20 | 2000 | 16 |
About Markus Welcker
Markus Welcker is a scholar working on Oncology, Cell Biology, Molecular Biology, Genetics and Biotechnology, having authored 31 papers that have together received 5.0k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (18 papers), Ubiquitin and proteasome pathways (17 papers), Microtubule and mitosis dynamics (7 papers), Peptidase Inhibition and Analysis (5 papers), Genetics and Neurodevelopmental Disorders (5 papers), RNA modifications and cancer (4 papers), Epigenetics and DNA Methylation (4 papers) and Protein Degradation and Inhibitors (4 papers). The work is most often cited by research in Oncology (2.2k citations), Cell Biology (1.1k citations), Molecular Biology (4.2k citations), Cancer Research (626 citations) and Hematology (298 citations). Markus Welcker has collaborated with scholars based in United States, Denmark and South Africa. Frequent co-authors include Bruce E. Clurman, Jonathan Grim, Amir Orian, Robert N. Eisenman, J. Wade Harper, Jianping Jin, Jiří Bártek, Ryan J. Davis, Niels Mailand and Jacob Falck. Their work appears in journals such as Current Biology, Molecular and Cellular Biology, Molecular Cell, The Journal of Experimental Medicine and Genes & Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.